Geographically, the blood screening market dominated by North America, followed by Europe, Asia, & Rest of the World (RoW). Growth of this market can be attributed to increasing adoption of nucleic acid tests (NAT) in region. In addition, increasing participation of various government associations in blood donations and screening & transfusion activities also supports growth of North American blood screening market. Learn details of the Growth Factors, Industry Trends and New Innovation for End Users
- Agency -.
Complete Report on Blood Screening Market spread across 150 Pages, Profiling 11 Companies and Supported with 97 Tables and 39 Figures is now available at www.rnrmarketresearch.com/blood-sc…arket-report.html .
The blood screening market is expected to reach USD 2.80 billion by 2021 from USD 1.76 billion in 2016, at a CAGR of 9.7%. The NAT segment is expected to grow at the highest CAGR during the forecast period.
Major factors contributing to the growth in this segment are increasing number of blood donations, rising incidence of various infectious diseases, and increasing disposable income to pay for advanced blood screening procedures including NAT-test.
- Agency -.
Target Audience for this Report:
- Blood Screening Instruments and Reagents Manufacturers
- Blood Screening Software and Services Providers
- Blood Banks
- Red Cross Societies
- Regulatory Bodies
- Research and Consulting Firms
- Government Bodies
The blood screening market is segmented into blood banks and hospitals. In 2016, the blood banks segment is expected to account for the largest of the market.
This is primarily due to the increasing number of organ transplantation surgeries, increasing demand for donated blood, rising awareness regarding the safety of blood, and increasing number of donations worldwide.
Globally, the blood screening market is witnessing substantial growth due to factors such as increasing number of blood donations and blood donors, growing affordability and adoption of nucleic acid test (NAT) for blood screening, rising awareness regarding the safety of donated blood, growing demand for donated blood, and increasing prevalence/incidence of infectious diseases.
Company Profiles (Introduction, Products & Services, Strategy, & Analyst Insights, Developments)
2 F. Hoffmann-La Roche
3 Abbott Laboratories
5 Bio-Rad Laboratories, Inc.
6 Siemens Healthineers (A Subsidiary of Siemens AG)
7 Ortho Clinical Diagnostics, Inc.
8 Thermo Fisher Scientific, Inc.
9 Beckman Coulter (A Subsidiary of Danaher Corporation)
10 Becton, Dickinson and Company
The global blood screening market is categorized based on technology, product & service, end-user, and region. The technology segment includes nucleic acid tests (NAT), enzyme-linked immunosorbent assay (ELISA), rapid tests, western blot assays, and next-generation sequencing (NGS).
Furthermore, some of major opportunities observed in this market include growing economies such as China and India, emergence of pathogen reduction technology, and demand of multiplex tests.
The major factors driving growth of this market are increasing number of blood donations and blood donors and rising awareness regarding safety of donated blood. In addition, increasing affordability and adoption of nucleic acid test (NAT) for blood screening, rising demand for donated blood, and increasing prevalence of infectious diseases are also driving growth of this market.
Category: Market Research Publishers and RetailersCompany profile: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
For more information: